Tommie Reerink

Stock Analyst at Goldman Sachs

(1.52)
# 3,274
Out of 4,761 analysts
3
Total ratings
66.67%
Success rate
-0.55%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Tommie Reerink

Atara Biotherapeutics
Jul 17, 2024
Maintains: Sell
Price Target: $13$11
Current: $7.11
Upside: +54.71%